Patent details

EP3024832 Title: 1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES

Basic Information

Publication number:
EP3024832
PCT Application Number:
EP2014065639
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP147440317
PCT Publication Number:
WO2015011099
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANONE DERIVATIVES
French Title of Invention:
DÉRIVÉS DE 1-(PIPÉRAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ÉTHANONE
German Title of Invention:
1-(PIPERAZIN-1-YL)-2-([1,2,4]TRIAZOL-1-YL)-ETHANON-DERIVATE
SPC Number:

Dates

Filing date:
21/07/2014
Grant date:
28/03/2018
EP Publication Date:
01/06/2016
PCT Publication Date:
29/01/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/03/2018
EP B1 Publication Date:
28/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/07/2018
Expiration date:
21/07/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/03/2018
 
 

Name:
Idorsia Pharmaceuticals Ltd
Address:
Hegenheimermattweg 91, 4123 Allschwil, Switzerland (CH)

Inventor

1

Name:
CAROFF, Eva
Address:
Switzerland (CH)

2

Name:
MEYER, Emmanuel
Address:
Switzerland (CH)

Priority

Priority Number:
PCT/IB2013/056001
Priority Date:
22/07/2013
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

IPC classification:
A61K 31/427; A61P 29/00; C07D 417/14;

Publication

European Patent Bulletin

Issue number:
201813
Publication date:
28/03/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/11/2018 Outgoing Correspondence 1